​

Funding Round

Series A - Arvelle Therapeutics

Series A - Arvelle Therapeutics

Investment Firm

Overview

Arvelle Therapeutics is a biopharmaceutical company with the mission of bringing innovative solution.

Announced Date

May 27, 2020

Funding Type

Series A

Highlights

Location

Switzerland, Europe

Social

Investor Lead

N/A

Participant Investors

7

Investor Name
Participant InvestorNovaquest Capital Management
Participant InvestorF-Prime Capital
Participant InvestorEQT Life Sciences
Participant InvestorAndera Partners
Participant InvestorH.I.G. BioHealth Partners

Round Details and Background

Arvelle Therapeutics raised $42700000 on 2020-05-27 in Series A

Arvelle Therapeutics is a biopharmaceutical company with the mission of bringing innovative solution.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Feb 18, 2019
Series A - Arvelle Therapeutics
5-179.1M
May 27, 2020
Series A - Arvelle Therapeutics
7-42.7M

Recent Activity

There is no recent news or activity for this profile.